Skip to main content

Animations

MJFF Publications

3721 - 3730 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2021
  • 2020
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology
    Journal Name: Expert Review of Medical Devices
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/17434440.2021.1962286
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Parkinson’s Disease Videos on YouTube: Types and Characteristics of Content on Communication and Cognition
    Journal Name: Journal of Consumer Health on the Internet
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/15398285.2021.1980692
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis
    Journal Name: Expert Review of Proteomics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/14789450.2021.2004890
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: The Impact of Cloud Management Platforms on Nonprofit Business Models
    Journal Name: Journal of Technology in Human Services
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/15228835.2021.1920556
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14737175.2021.1923480
    Citation Count: 16
  • Summary Details
    OPEN
    Title: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspective
    Journal Name: Research Policy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270
    Citation Count: 217
  • Summary Details
    RESTRICTED
    Title: The plight of loneliness in Parkinson's disease: New opportunities
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.